NIM
REGN icon

NEOS Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

NEOS Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.2M Buy
77,322
+6,921
+10% +$4.71M 0.18% 102
2026
Q1 		$54.4M Buy
70,401
+8,147
+13% +$6.24M 0.27% 64
2025
Q4 		$48.1M Buy
62,254
+14,081
+29% +$9.56M 0.28% 64
2025
Q3 		$27.1M Buy
48,173
+16,123
+50% +$9.12M 0.2% 91
2025
Q2 		$16.8M Buy
32,050
+11,164
+53% +$6.23M 0.21% 94
2025
Q1 		$13.2M Buy
20,886
+3,236
+18% +$2.23M 0.25% 79
2024
Q4 		$12.6M Buy
17,650
+4,140
+31% +$3.47M 0.3% 62
2024
Q3 		$14.2M Buy
13,510
+1,868
+16% +$2.08M 0.43% 47
2024
Q2 		$12.2M Buy
11,642
+4,032
+53% +$3.91M 0.5% 37
2024
Q1 		$7.32M Buy
7,610
+1,534
+25% +$1.46M 0.45% 41
2023
Q4 		$5.34M Buy
6,076
+1,271
+26% +$1.05M 0.51% 38
2023
Q3 		$3.95M Buy
+4,805
New +$3.78M 0.51% 42

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

NEOS Investment Management's REGN Position: Q2 2026 in Review

NEOS Investment Management increased its Regeneron Pharmaceuticals (REGN) stake by 9.8% in Q2 2026, buying an estimated $4.71M and bringing the position to 77,322 shares worth $48.2M. The position accounts for 0.18% of the portfolio, ranked #102.

NEOS Investment Management first reported a position in REGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $54.4M in Q1 2026. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • NEOS Investment Management held 77,322 shares of Regeneron Pharmaceuticals worth $48.2M as of Q2 2026.
  • NEOS Investment Management bought 6,921 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $4.71M.
  • Regeneron Pharmaceuticals made up 0.18% of NEOS Investment Management's portfolio in Q2 2026, its #102 holding.
  • NEOS Investment Management first reported a position in Regeneron Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • NEOS Investment Management's Regeneron Pharmaceuticals position peaked at $54.4M in Q1 2026.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.